Scott Koenig - 08 Feb 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: President and CEO, Director
Signature: Beth A. Smith, Attorney-in-fact
Issuer symbol: MGNX
Transactions as of: 08 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 11 Feb 2025, 20:28:10 UTC
Previous filing: 09 Oct 2024
Next filing: 19 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Award	$0	+31,673	+4.5%	$0.000000	735,086	08 Feb 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Restricted Stock Unit	Options Exercise	$0	-31,673	-33%	$0.000000	63,327	08 Feb 2025	Common Stock	31,673		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.